All News

Patients with HER2-positive metastatic breast cancer who received pertuzumab (Perjeta, Roche) as part of their chemotherapy regimen had a significantly longer median survival rate-by almost 16 months-compared with those who only received the trastuzumab/docetaxel regimen, according to a presentation during the 2014 Congress of the European Society for Medical Oncology in Spain.

A new California law will free up hospital pharmacists in the state to spend more time with patients and collaborate with other healthcare providers.

A New York legislator said he plans to introduce a bill aimed at preventing an Upper East Side pharmacy from charging 9/11 responders $150 to obtain printouts of their records.

FDA has approved two new HIV-1 cocktail drugs: elvitegravir (Vitekta, Gilead), an integrase inhibitor and cobicistat (Tybost, Gilead), a protease-inhibitor booster.

The Medical College of Wisconsin (MCW) is planning a feasibility study to examine whether it should open a new pharmacy school in either Green Bay or elsewhere in the state.

Pharmacists around the world, on Thursday, Oct. 2, are expected to tweet about the things they do to help patients, communities, and the healthcare industry.

Have pharmacists uncritically accepted the pill-for-every-ill mentality?

How often do patients reach out to pharmacists in brick-and-mortar stores? The answer may surprise you.

FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.

President Obama recently signed an executive order establishing a taskforce charged with creating a strategy to combat antibiotic-resistant bacteria.

A Wisconsin pharmacist has been arraigned on charges she and a partner tried to smuggle more than four million misbranded and counterfeit pills into the United States.

FDA has approved dulaglutide (Trulicity, Eli Lilly) to treat type 2 diabetes mellitus. The drug is a once-weekly subcutaneous injection used to improve glycemic control and is indicated as an adjunct to diet and exercise in the management of type 2 diabetes in adults.

California Gov. Jerry Brown recently signed legislation that makes the state the sixth to allow access to the overdose antidote naloxone without a prescription.

The West Virginia Board of Pharmacy has created a list of suspected “doctor shoppers” and given it to law enforcement officials, according to a report in the Charleston Gazette.

Now that the Drug Enforcement Agency has tightened restrictions on hydrocodone combination products by reclassifying them as Schedule II controlled substances, how should pharmacies prepare for the change?

Two fathers and their sons keep the ideals of small-town pharmacy practice alive for 65 years.

Researchers from the Centers for Disease Control and Prevention (CDC) and FDA undertook a study to determine the most commonly implicated active ingredients responsible for childhood poisonings that required emergency hospitalization in the hope of identifying prevention and intervention strategies. Buprenorphine and clonidine were the most common of 12 active ingredients that were found in 45.0% of these hospitalizations.

The overprescribing of antibiotics by hospitals may be producing $163 million in excess costs, according to a study published in Infection Control and Hospital Epidemiology.

An advisory committee to the FDA voted 14 to 1 to approve liraglutide for injection for chronic weight management in some obese patients.

A third weight-management drug, Contrave, has received FDA approval for use in obese and overweight adults.

One in five males were unable to buy the emergency contraceptive Plan B in several New York City pharmacies, according to a study published in the journal Contraception.

William Carey University (WCU) in Mississippi is trying to raise $4 million for upfront costs for a new pharmacy school.

Proposed legislation that would cover home-based infusion therapy for Medicare beneficiaries could save the healthcare system approximately $80 million over 10 years and provide access to life-saving care at patients’ homes. The potential savings is outlined in a report released in June by Avalere.

A literature review going back 20 years found only a modest increase in patients' risk of developing statin-related conditions.

He's not filling a niche, he's serving a need, says pharmacist Frank Vostatek, who can add "role model" to the rest of his job description.

Albiglutide injection is the newest GLP-1 approved for once-weekly dosing in patients with type II diabetes, to be used in addition to diet and exercise.

It's back-to-school season. Mom and Dad can be losing their hair for a few reasons - finding something crawling on the kids' heads is just the beginning. Here's a host of solutions for parents and their young.

Letters, e-mails, posts, and tweets from the readers of Drug Topics magazine.